Tag: matches
Novartis, stressing Beovu safety, matches Eylea in head-to-head diabetic macular edema...
Novartis is aiming its new eye drug Beovu, a challenger to Regeneron's Eylea, at another of its rival's key markets. And amid a raft...
ADA: Novo Nordisk’s long-lasting insulin candidate matches Lantus in phase 2
Novo Nordisk has long been working on drugs that can help people earlier on in their diabetes and keep them from progressing to insulin...